ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) EV to EBITDA (2013 - 2023)

Analysis

ProPhase Labs (PRPH) EV to EBITDA (2013 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 8.82
Dec 31, 2022 4.90
Sep 30, 2022 3.32
Jun 30, 2022 4.24
Mar 31, 2022 2.76
Dec 31, 2021 7.20
Mar 31, 2021 88.75
Dec 31, 2013 38.22
Sep 30, 2013 58.05
Jun 30, 2013 58.64
Mar 31, 2013 157.75
API Access

ProPhase Labs EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PRPH&period=max&api_key=YOUR_API_KEY